
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **PLN (Phospholamban):** Involved in cardiac muscle contraction regulation, but also expressed in smooth muscle cells.<br>- **RGS5 (Regulator of G-protein Signaling 5):** Known to be involved in the regulation of vascular smooth muscle contraction and is a marker for pericytes.<br>- **GJA4 (Gap Junction Protein Alpha 4):** Encodes connexin 37, involved in cell communication, particularly in endothelial cells.<br>- **MYH11 (Myosin Heavy Chain 11):** A smooth muscle-specific myosin heavy chain, indicating smooth muscle cell identity.<br>- **ACTA2 (Alpha-Smooth Muscle Actin):** A classic marker for smooth muscle cells and myofibroblasts.<br>- **PDGFRB (Platelet-Derived Growth Factor Receptor Beta):** Expressed in pericytes and vascular smooth muscle cells, involved in blood vessel development.<br>- **IL6 (Interleukin 6):** A cytokine involved in inflammation and immune response, can be expressed in various cell types including fibroblasts and immune cells.<br>- **COL4A1 and COL4A2 (Collagen Type IV Alpha 1 and 2 Chains):** Components of the basement membrane, often expressed in endothelial cells and fibroblasts.<br>- **SPARCL1 (SPARC-Like 1):** Involved in cell adhesion and migration, often expressed in endothelial cells and fibroblasts.<br>- **CAV1 (Caveolin 1):** A structural protein of caveolae, involved in signal transduction, expressed in endothelial cells and fibroblasts.<br>- **NOTCH3:** Involved in vascular development and smooth muscle cell differentiation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **MYH11, ACTA2, TAGLN (Transgelin):** Strong markers for smooth muscle cells.<br>- **RGS5, PDGFRB:** Markers for pericytes, which are associated with blood vessels.<br>- **GJA4, COL4A1, COL4A2, SPARCL1, CAV1:** Markers for endothelial cells.<br>- **IL6, ADAMTS1, ADAMTS4:** Can be expressed in fibroblasts and immune cells, but not specific.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can confirm that:<br>- **Smooth Muscle Cells:** Express MYH11, ACTA2, TAGLN.<br>- **Pericytes:** Express RGS5, PDGFRB.<br>- **Endothelial Cells:** Express GJA4, COL4A1, COL4A2, SPARCL1, CAV1.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of MYH11, ACTA2, TAGLN, and other smooth muscle-related markers, the most probable general cell type is **Smooth Muscle Cells**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Vascular Smooth Muscle Cells:** Given the strong expression of MYH11, ACTA2, and PDGFRB, which are specific to vascular smooth muscle cells.<br>2. **Pericytes:** Due to the presence of RGS5 and PDGFRB, which are also expressed in pericytes.<br>3. **Myofibroblasts:** Although less likely, the presence of ACTA2 and IL6 could suggest a myofibroblast phenotype, especially in a cancer context.<br><br>The most likely subtype based on the markers is **Vascular Smooth Muscle Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cluster of cells is most likely composed of **Vascular Smooth Muscle Cells**. This conclusion is supported by the high expression of smooth muscle-specific markers such as MYH11, ACTA2, and TAGLN, along with PDGFRB, which is indicative of vascular association. The presence of pericyte markers like RGS5 further supports a vascular-related cell type.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key markers used in the annotation (e.g., MYH11, ACTA2, TAGLN, RGS5, PDGFRB, GJA4, COL4A1, COL4A2, SPARCL1, CAV1) are present in the provided marker list.<br>   - The markers are consistent with the identified cell types: smooth muscle cells, pericytes, and endothelial cells.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The analysis acknowledges the presence of markers for pericytes and endothelial cells, suggesting a potential mixed cell population.<br>   - The annotation appropriately flags pericytes and myofibroblasts as possible subtypes, which is reasonable given the marker expression.<br><br>3. **Conclusion:**<br>   - The annotation of the cell cluster as primarily composed of vascular smooth muscle cells is well-supported by the high expression of smooth muscle-specific markers.<br>   - The consideration of pericytes and myofibroblasts as potential subtypes is appropriate and aligns with the marker data.<br><br>Overall, the annotation process was thorough, and the conclusions drawn are justified based on the marker expression data provided.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Smooth Muscle Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Vascular Smooth Muscle Cells</li><li>Pericytes</li><li>Myofibroblasts</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough and methodical approach to identifying the cell types present in the single-cell dataset derived from human breast cancer tissue. The analysis effectively utilizes a wide range of markers to determine the most probable cell types, with a primary focus on smooth muscle cells, particularly vascular smooth muscle cells. This conclusion is well-supported by the presence of key markers such as MYH11, ACTA2, and TAGLN, which are classic indicators of smooth muscle cell identity.<br><br>Strengths of the annotation include:<br>1. **Comprehensive Marker Analysis:** The annotation process considers a broad spectrum of markers, including those for smooth muscle cells, pericytes, and endothelial cells. This balanced approach ensures that the analysis does not overly focus on a single marker but rather integrates multiple lines of evidence to reach a conclusion.<br>2. **Consideration of Mixed Cell Populations:** The analysis acknowledges the potential presence of mixed cell types, such as pericytes and myofibroblasts, which is a realistic consideration given the complexity of tumor microenvironments.<br>3. **Use of Databases for Validation:** The cross-referencing with known databases like the Human Protein Atlas and PanglaoDB adds a layer of validation to the marker-based conclusions, enhancing the scientific accuracy of the annotations.<br><br>However, there are some areas for improvement:<br>1. **Marker Ranking Consideration:** While the analysis is comprehensive, it does not explicitly address the rank or order of the markers in the list. Given that markers appearing earlier may hold more significance, this aspect could have been more explicitly integrated into the final conclusions.<br>2. **Potential Overlook of Other Cell Types:** Although the focus on vascular smooth muscle cells is justified, the analysis could have explored other potential cell types that might be present, especially given the diverse nature of breast cancer tissues.<br><br>Overall, the annotation provides a scientifically accurate and well-rounded view of the cell populations, with a strong emphasis on smooth muscle cells. The consideration of multiple markers and potential mixed cell types reflects a deep understanding of the data, although a more explicit consideration of marker ranking could enhance the analysis.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    